Alzinova AB Logo

Alzinova AB

Developing targeted immunotherapies, including a vaccine, for Alzheimer's disease.

ALZ | ST

Overview

Corporate Details

ISIN(s):
SE0007413455
LEI:
549300K3IMVT20EK2S13
Country:
Sweden
Address:
Pepparedsleden 1, 431 83 MÖLNDAL
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Alzinova AB is a clinical-stage biopharmaceutical company specializing in the development of disease-modifying treatments for Alzheimer's disease. The company's research is centered on its proprietary AβCC Peptide™ technology, which enables the development of immunotherapies that specifically target neurotoxic amyloid-beta oligomers, a central cause of the disease. Alzinova's pipeline includes both active immunotherapies (vaccines) and passive immunotherapies (antibodies). Its lead candidate, ALZ-101, is a therapeutic vaccine in clinical development designed to be a highly specific treatment to prevent or slow the progression of Alzheimer's disease.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Alzinova AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Alzinova AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Alzinova AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-03 Tord Evert Sigfried Labuda Other Other 1,000,000 260,000.00 SEK
2025-04-03 Tord Evert Sigfried Labuda Other Buy 10,000 18,800.00 SEK
2025-04-02 Tord Evert Sigfried Labuda Other Buy 20,000 40,000.00 SEK
2024-12-16 Erik Kullgren Other Buy 10,000 34,400.00 SEK

Peer Companies

Company Country Ticker View
Icure Pharmaceutical Incorporation Logo
Develops transdermal patches for dementia/Parkinson's and offers cosmetic ODM/OBM services.
South Korea 175250
Idorsia Ltd Logo
Develops and commercializes small-molecule medicines for CNS, cardiovascular, and immune disorders.
Switzerland IDIA
IL DONG PHARMACEUTICAL CO., LTD. Logo
Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.
South Korea 249420
ILSUNG IS CO., LTD. Logo
Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.
South Korea 003120
ILYANG PHARMACEUTICAL CO.,LTD Logo
Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.
South Korea 007570
ImmuneOncia Therapeutics, Inc. Logo
A biopharma firm developing immune checkpoint inhibitors for cancer immunotherapy.
South Korea 424870
Immuno-Biological Laboratories Co., Ltd. Logo
Develops and supplies immunological reagents and diagnostics for research and drug discovery.
Japan 4570
Develops targeted dermatology & oncology therapies using unique formulation & delivery technologies.
United Kingdom N/A
Indivior PLC Logo
Develops pharmaceuticals for opioid use disorder, addiction, and serious mental illnesses.
United Kingdom INDV
Infant Bacterial Therapeutics Logo
Develops live bacterial medicines to prevent rare, severe gut diseases in premature infants.
Sweden IBT

Talk to a Data Expert

Have a question? We'll get back to you promptly.